AD 3
Add 1
Ad 2

NIH panel refutes FDA’s claims of the benefits of coronavirus plasma treatment

The panel said it reviewed available data on the treatment and found nothing from “well-controlled, adequately powered randomized clinical trials that demonstrate the efficacy and safety of convalescent plasma.”

Leave A Reply